Communiqués Motus GI Holdings, Inc.

Actions

MOTS

US62014P5044

Equipement et technologie médicale avancés

Temps réel OTC Markets 17:49:24 31/12/2025			Varia. 5j.	Varia. 1 janv.
0,000100 ^USD	-.--%		-50,00%	-

31/07/24	Motus GI Holdings, Inc. annonce la démission de Mark Pomeranz à titre de chef de la direction	CI
31/07/24	Motus GI Holdings, Inc. annonce des changements au sein de son conseil d'administration	CI

Communiqués

31/07/24	Motus GI : Submission of Matters to a Vote of Security Holders Form 8 K	PU
14/05/24	Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update	AQ
18/03/24	Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	AQ
22/02/24	Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds	AQ
21/02/24	Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract	AQ
16/02/24	Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders	AQ
30/01/24	Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation	AQ
19/12/23	Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering	AQ
13/11/23	Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update	AQ
10/11/23	Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro	AQ
01/11/23	Motus GI Announces 1-for-15 Reverse Stock Split	AQ
24/10/23	Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon	AQ
26/09/23	Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon	AQ
14/09/23	Motus GI Amends Royalty Agreement	AQ
06/09/23	Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors	AQ
24/08/23	Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference	AQ
14/08/23	Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update	AQ
10/08/23	Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System	AQ
20/07/23	Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center	AQ
14/06/23	Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center	AQ
05/06/23	Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer	AQ
18/05/23	Motus GI Announces $3.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules	AQ
17/05/23	Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission	AQ
11/05/23	MOTUS GI HOLDINGS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/05/23	Motus GI Announces DDW 2023 Clinical Study Presentation Showing Pure-Vu EVS Drove a 33% Hospital-Wide Improvement in Incomplete Bowel Prep Rate at Minneapolis VA Medical Center	AQ